Keywords: PGE1، پروستاگلاندین E1; ADP, adenosine-5′-diphosphate; c AMP, cyclic adenosine 3′,5′-monophosphate; c GMP, cyclic guanosine 3′,5′-monophosphate; INR, international normalized ratio; NO, nitric oxide; PRI, Platelet Reactivity Index; PGE1, prostaglandin E1; PGI2, prostacyclin; sGC
مقالات ISI PGE1، پروستاگلاندین E1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PGE1، پروستاگلاندین E1; AS, aortic valve stenosis; SS, shear stress; AV, aortic valve; PLA, platelet-leukocyte aggregate; WD, western type diet; PSGL-1, P-selectin glycoprotein ligand-1; PGE1, prostaglandin E1; MLEC, mink lung epithelial cells; EF, ejection fraction; FS, fractio
Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies
Keywords: PGE1، پروستاگلاندین E1; ADP, adenosine diphosphate; ATP, adenosine triphosphate; CRP, collagen-related peptide; DMSO, dimethyl sulfoxide; EDTA, ethylene diamine tetraacetic acid; PGE1, Prostaglandin E1; PI3K, Phosphoinositide 3-kinase; PPP, platelet-poor plasma; PRP, platelet-ri
The Use of Inhaled Prostaglandins in Patients With ARDS
Keywords: PGE1، پروستاگلاندین E1; iNO, inhaled nitric oxide; mPAP, mean pulmonary artery pressure; PGE1, prostaglandin E1; PGI2, prostaglandin I2; RCT, randomized controlled trial
Timing of complete repair of non–ductal-dependent tetralogy of Fallot and short-term postoperative outcomes, a multicenter analysis
Keywords: PGE1، پروستاگلاندین E1; 20ECMO, extracorporeal membrane oxygenation; ED, emergency department; ICD-9, International Classification of Diseases, 9th revision; ICU, intensive care unit; LOS, length of stay; PGE1, prostaglandin E1; PHIS, Pediatric Health Information System; TOF, te
Pharmacodynamic Effects During the Transition Between Cangrelor and Ticagrelor
Keywords: PGE1، پروستاگلاندین E1; antiplatelet; cangrelor; pharmacodynamics; ticagrelor; transitionADP, adenosine diphosphate; CAD, coronary artery disease; CI, confidence interval; LTA, light transmission aggregometry; MFI, mean fluorescence intensity; PGE1, prostaglandin E1; VASP, vasod
Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo
Keywords: PGE1، پروستاگلاندین E1; cPLA2, cytosolic phospholipase A2; ESR, electron spin resonance; HO, hydroxyl radical; MRP4, multidrug resistance protein 4; PKA, protein Kinase A; PKC, protein kinase C; PKG, protein kinase G; PRP, platelet-rich plasma; PGE1, prostaglandin E1; ROS, react
Treatments for fibrosis of the corpora cavernosa
Keywords: PGE1، پروستاگلاندین E1; PD, Peyronie’s disease; ED, erectile dysfunction; PGE1, prostaglandin E1; ICI, intracavernous injection; PDE5I, phosphodiesterase 5 inhibitorsPenile fibrosis; Corporal fibrosis; Therapy; Surgery; Erectile dysfunction
Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation
Keywords: PGE1، پروستاگلاندین E1; ADP, adenosine diphosphate; cAMP, cyclic adenosine monophosphate; DMSO, dimethyl sulfoxide; EDTA, ethylenediaminetetraacetic acid; GSK3β, glycogen synthase kinase 3β; MAPK, mitogen-activated protein kinase; PGE1, prostaglandin E1; PKC, protein kinase C; P
Platelet aggregometry in the presence of PGE1 provides a reliable method for cilostazol monitoring
Keywords: PGE1، پروستاگلاندین E1; PDE3, phosphodiesterase 3; PGE1, prostaglandin E1; AA, arachidonic acid; VASP, Vasodilator-stimulated Phosphoprotein; ROC, receiver operating characteristic; AUC, area under the curve; IPA, inhibition rates of platelet aggregationCilostazol; Antiplatelet
Involvement of proton-sensing receptor TDAG8 in the anti-inflammatory actions of dexamethasone in peritoneal macrophages
Keywords: PGE1، پروستاگلاندین E1; DEX, dexamethasone; TDAG8, T-cell death associated gene 8; TNF-α, tumor necrosis factor-α; GC, glucocorticoid; LPS, lipopolysaccharide; PGE1, prostaglandin E1; GAPDH, glyceraldehydes 3-phosphate dehydrogenase; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanes
Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
Keywords: PGE1، پروستاگلاندین E1; ED, erectile dysfunction; CDUS, colour Doppler ultrasonography; PGE1, prostaglandin E1; EH(S), Erection Hardness (Score); ICI, intracavernous injection; PSV, peak systolic velocity; EDV, end-diastolic velocity; RI, resistance index; PDE, phosphodiesterase
Abnormally extended ductal tissue into the aorta is indicated by similar histopathology and shared apoptosis in patients with coarctation
Keywords: PGE1، پروستاگلاندین E1; CoA, coarctation of the aorta; CS, coarctation segment; DA, ductus arteriosus; DT, ductal tissue in the aorta; IC, intimal cushion; PDA, patent ductus arteriosus; PGE1, prostaglandin E1; SMA, smooth muscle actin; SMC, smooth muscle cell; TZ, transition zo
A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation
Keywords: PGE1، پروستاگلاندین E1; ADP, adenosine diphosphate; ATP, adenosine triphosphate; c7E3, chimeric 7E3 antibody; GP, glycoprotein; PGE1, prostaglandin E1; PRP, platelet-rich plasma; SSRI, selective serotonin reuptake inhibitor; TxA2, thromboxane A2; TxB2, thromboxane B2Citalopram;
Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention : The OMEGA-PCI (OMEGA-3 Fatty Acids After PCI to Modify Responsiveness to Dual Antiplatelet Therapy) S
Keywords: PGE1، پروستاگلاندین E1; aspirin; clopidogrel; coronary stenting; omega-3 fatty acidsAA, arachidonic acid; ADP, adenosine diphosphate; PRI, P2Y12reactivity index; PCI, percutaneous coronary intervention; PGE1, prostaglandin E1; PUFA, polyunsaturated fatty acid; VASP, vasodilator-
Allicin and disulfiram enhance platelet integrin αIIbβ3-fibrinogen binding
Keywords: PGE1، پروستاگلاندین E1; ADP, adenosine diphosphate; LIBS, ligand induced binding site; BHK, baby hamster kidney; DTT, dithiothreitol; PGE1, prostaglandin E1; BSA, bovine serum albumin; DTNB, dithiobis nitrobenzoic acid; GSH, glutathione; PBS, phosphate buffered saline; DMEM, Dul
Effect of aerosolized PGE1 on the ductus arteriosus of neonatal swine
Keywords: PGE1، پروستاگلاندین E1; NHRF, neonatalhypoxemic respiratory failure; PPHN, persistent pulmonary hypertension of the newborn; DA, ductus arteriosus; PaO2, arterial oxygen tension; PGE1, prostaglandin E1; IPGE1, inhaled Prostaglandin E1; ivPGE1, intravenous PGE1Neonatal hypoxemic
Coarctation repair in neonates and young infants: Is small size or low weight still a risk factor?
Keywords: PGE1، پروستاگلاندین E1; PGE1, prostaglandin E1; VSD, ventricular septal defect20; 26
Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance : A Multicenter Randomized Prospective Study
Keywords: PGE1، پروستاگلاندین E1; ADP, adenosine diphosphate; MACE, major adverse cardiac events; MFI, mean fluorescence intensity; NSTEMI, non–ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; PGE1, prostaglandin E1; TIMI, Thrombolysis In Myocardial Inf
Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention : Results From the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) Randomized Study
Keywords: PGE1، پروستاگلاندین E1; clopidogrel; coronary stenting; platelet functionADP, adenosine diphosphate; CI, confidence interval; MFI, mean fluorescence intensity; OR, odds ratio; PCI, percutaneous coronary intervention; PGE1, prostaglandin E1; PPI, proton-pump inhibitor; PRI, plate
Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs
Keywords: PGE1، پروستاگلاندین E1; Pulmonary toxicity; Inhaled; PGE1/Alprostadil; Neonatal; Piglet/animal; Histomorphology; Nebulizer; AerosolETT, endotracheal tube; NHRF, neonatal hypoxemic respiratory failure; PPHN, persistent pulmonary hypertension of the newborn; PGE1, prostaglandin E1